SE435997B - Forfarande for framstellning av en stabil losning av ett tetracyklinantibiotikum - Google Patents

Forfarande for framstellning av en stabil losning av ett tetracyklinantibiotikum

Info

Publication number
SE435997B
SE435997B SE7613959A SE7613959A SE435997B SE 435997 B SE435997 B SE 435997B SE 7613959 A SE7613959 A SE 7613959A SE 7613959 A SE7613959 A SE 7613959A SE 435997 B SE435997 B SE 435997B
Authority
SE
Sweden
Prior art keywords
preparing
procedure
stable solution
tetracyclin
antibiotic
Prior art date
Application number
SE7613959A
Other languages
English (en)
Swedish (sv)
Other versions
SE7613959L (sv
Inventor
William Wellesley Armstrong
Saurabhkumar Jayavantrai Desai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to MX603976A priority Critical patent/MX155116A/es
Priority to MX604076A priority patent/MX154913A/es
Priority to MX603876A priority patent/MX155081A/es
Priority to MX524476U priority patent/MX6648E/es
Publication of SE7613959L publication Critical patent/SE7613959L/
Publication of SE435997B publication Critical patent/SE435997B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
SE7613959A 1976-01-02 1976-12-10 Forfarande for framstellning av en stabil losning av ett tetracyklinantibiotikum SE435997B (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MX603976A MX155116A (es) 1976-01-02 1976-12-17 Procedimiento para preparar soluciones acuosas de clorotetraciclina en 2-pirrolidona
MX604076A MX154913A (es) 1976-01-02 1976-12-17 Procedimiento para preparar soluciones acuosas de tetraciclina en 2-pirrolidona
MX603876A MX155081A (es) 1976-01-02 1976-12-17 Procedimiento para preparar soluciones acuosas de doxiciclima en 2-pirrolidona
MX524476U MX6648E (es) 1976-01-02 1976-12-17 Procedimiento para preparar soluciones acuosas de oxitetraciclina,en 2-pirrolidona

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/646,295 US4018889A (en) 1976-01-02 1976-01-02 Oxytetracycline compositions
CA268,177A CA1075603A (en) 1976-01-02 1976-12-17 Stable solutions of doxycycline in aqueous 2-pyrrolidone
KR7700012A KR810000900B1 (ko) 1976-01-02 1977-01-06 항생물질 조성제의 안정화 방법

Publications (2)

Publication Number Publication Date
SE7613959L SE7613959L (sv) 1977-07-03
SE435997B true SE435997B (sv) 1984-11-05

Family

ID=27164830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613959A SE435997B (sv) 1976-01-02 1976-12-10 Forfarande for framstellning av en stabil losning av ett tetracyklinantibiotikum

Country Status (29)

Country Link
US (3) US4018889A (cs)
JP (1) JPS5290616A (cs)
KR (1) KR810000900B1 (cs)
AR (1) AR209242A1 (cs)
AT (1) AT345977B (cs)
BE (1) BE849885A (cs)
BG (1) BG36493A3 (cs)
CA (2) CA1075603A (cs)
CH (1) CH616080A5 (cs)
CS (1) CS205030B2 (cs)
DD (1) DD129997A5 (cs)
DE (1) DE2659152C2 (cs)
DK (1) DK145753C (cs)
EG (1) EG12291A (cs)
FI (1) FI56116C (cs)
FR (1) FR2336937A1 (cs)
GB (1) GB1520197A (cs)
GR (1) GR65305B (cs)
HK (1) HK30181A (cs)
IE (1) IE44767B1 (cs)
IN (1) IN145845B (cs)
KE (1) KE3166A (cs)
LU (1) LU76493A1 (cs)
NL (1) NL166620C (cs)
OA (1) OA05524A (cs)
PT (1) PT66017B (cs)
SE (1) SE435997B (cs)
SU (1) SU1309901A3 (cs)
ZA (1) ZA767689B (cs)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126680A (en) * 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
EP0009559B1 (de) * 1978-08-01 1982-08-25 Ciba-Geigy Ag Stabile flüssige Arzneimittelformulierung, ihre Herstellung und Verwendung
EP0012496B1 (en) * 1978-12-08 1983-07-20 Beecham Group Plc A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
NZ194192A (en) * 1979-07-02 1982-11-23 Pfizer Long-acting injectable composition containing sulfadimethoxine or sulfamethazine
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
ATE3750T1 (de) * 1979-07-05 1983-06-15 Pfizer Inc. Sulfonamidloesungen.
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
NL178941C (nl) * 1982-06-15 1986-06-16 Aesculaap Bv Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
US4769232A (en) * 1984-03-22 1988-09-06 Pfizer Inc. Parenteral formulations of indolmycin
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
FR2608044B1 (fr) * 1986-12-10 1992-09-11 Sogeval Composition antibiotique aqueuse a usage veterinaire
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
HRP20020322B1 (en) 1999-09-14 2009-04-30 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
AU2001228454A1 (en) * 2000-01-13 2001-07-24 Merck Patent G.M.B.H Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
WO2001052858A1 (en) 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
ATE365710T1 (de) * 2000-03-31 2007-07-15 Tufts College 7- und 9-carbamat, harnstoff, thioharnstoff, thiocarbamat und heteroaryl-amino substituierte tetracyclinverbindungen
EP1286954B1 (en) * 2000-05-15 2004-04-14 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
WO2001098236A2 (en) * 2000-06-16 2001-12-27 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
AU7164201A (en) 2000-07-07 2002-01-21 Tufts College 7-substituted tetracycline compounds
WO2002004404A2 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
MXPA03000036A (es) 2000-07-07 2003-07-14 Tufts College Compuestos de metaciclina sustituidos en posicion 13.
ATE544745T1 (de) 2000-07-07 2012-02-15 Tufts College 9-substituierte minocyclinverbindungen
RU2178698C1 (ru) * 2000-11-28 2002-01-27 Закрытое Акционерное Общество "Нита-Фарм" Способ получения композиции магниевого комплекса окситетрациклина пролонгированного действия
ATE404528T1 (de) 2001-03-13 2008-08-15 Paratek Pharm Innc 7,9 substituierte tetracyclinverbindungen
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
WO2002072506A2 (en) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP1241160A1 (en) * 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
WO2002072022A2 (en) * 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
US7045507B2 (en) 2001-03-14 2006-05-16 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
CA2444899C (en) 2001-04-24 2011-06-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
EP2995610A1 (en) 2002-01-08 2016-03-16 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EP2301534A1 (en) 2002-03-08 2011-03-30 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
CN101712632A (zh) 2002-03-21 2010-05-26 帕拉特克药品公司 取代的四环素化合物
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
EA012136B1 (ru) 2002-07-12 2009-08-28 Пэрэтек Фамэсьютикэлс, Инк. Замещенные соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
WO2004038001A2 (en) 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2004060425A2 (en) * 2002-12-27 2004-07-22 Angiotech International Ag Compositions and methods of using collagen and mmpi
AU2004259661B2 (en) 2003-07-09 2011-11-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
CN101863841A (zh) 2003-07-09 2010-10-20 帕拉特克药品公司 取代的四环素化合物
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
AU2004261143B2 (en) * 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
WO2005070878A1 (en) * 2004-01-15 2005-08-04 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
WO2006047756A2 (en) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2585418A1 (en) * 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
CN103919732A (zh) * 2005-01-21 2014-07-16 沃纳奇尔科特有限责任公司 固体剂型形式的四环素类金属络合物
CA2597212A1 (en) 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
EP1910273A2 (en) * 2005-07-21 2008-04-16 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
EP2298324A1 (en) 2006-01-24 2011-03-23 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
WO2007120913A2 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
DE202007019460U1 (de) * 2006-04-24 2012-10-24 Teva Pharmaceutical Industries Ltd. Kristalline Tigecyclin-Formen
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
EP2218785A3 (en) * 2006-05-15 2010-12-29 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
EP3812372A3 (en) 2006-12-21 2021-06-30 Paratek Pharmaceuticals, Inc. 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases
SI2120963T1 (sl) 2006-12-21 2019-02-28 Paratek Pharmaceuticals, Inc. Substituirane spojine tetraciklina za zdravljenje vnetnih kožnih motenj
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2008127722A1 (en) * 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
CA2688662A1 (en) 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
PT2176216E (pt) 2007-07-06 2012-07-27 Paratek Pharm Innc Métodos de síntese de minociclina substituída na posição 9
CA2717703A1 (en) 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US20100022483A1 (en) * 2008-04-14 2010-01-28 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
TW202216656A (zh) 2008-05-19 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
AP2011005631A0 (en) * 2008-09-19 2011-04-30 Paratek Pharmaceuticals Ind Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment.
US20120121706A1 (en) 2009-04-10 2012-05-17 Tufts Medical Center, Inc. PAR-1 Activation by Metalloproteinase-1 (MMP-1)
PL2568987T3 (pl) 2010-05-12 2017-06-30 Rempex Pharmaceuticals, Inc. Kompozycje tetracyklinowe
CA2835876C (en) 2011-05-12 2020-04-14 Paratek Pharmaceuticals, Inc. Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2015021387A2 (en) * 2013-08-09 2015-02-12 Britt George N Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
CN103536530A (zh) * 2013-10-30 2014-01-29 王玉万 盐酸多西环素长效注射剂及制备方法
AU2016235237B2 (en) 2015-03-23 2021-03-11 BioPharmX, Inc. Pharmaceutical tetracycline composition for dermatological use
CN104721133B (zh) * 2015-04-14 2018-05-18 四川美嘉龙生物科技有限公司 一种土霉素制剂及制备方法
CA3042514A1 (en) 2016-11-01 2018-05-11 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
ES2962380T3 (es) 2017-07-21 2024-03-18 Almirall Llc Sareciclina para el tratamiento de lesiones de acné no inflamatorias
JP7386170B2 (ja) 2017-11-28 2023-11-24 シーレクター ゲーエムベーハー トレハロースホスホリラーゼバリアントを使用するトレハロースの生産方法
US11426351B2 (en) 2019-12-26 2022-08-30 Sunstar Inc. Process for producing a pharmaceutical composition containing micro particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB805026A (en) * 1956-03-02 1958-11-26 Konink Nl Gisten Spiritusfabri Process for enhancing the solubility of medicines in water
GB802111A (en) * 1956-09-25 1958-10-01 Irwin Irville Lubowe Improved non-toxic pesticidal compositions
US2990331A (en) * 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
DE1091287B (de) * 1957-04-09 1960-10-20 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung stabiler, waessriger Loesungen von Tyrothricin und Subtilin
US2980584A (en) * 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2987437A (en) * 1958-03-06 1961-06-06 Gen Aniline & Film Corp Nematocidal composition
US3062717A (en) * 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3957972A (en) * 1966-05-31 1976-05-18 Koninklijke Nederlandsche Gist-En Spiritusfabriek N.V. Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
NL6607516A (cs) * 1966-05-31 1967-12-01
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
GB1508601A (en) * 1974-01-19 1978-04-26 Norbrook Labor Ltd Oxytetracycline solution
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
GB1538903A (en) 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent

Also Published As

Publication number Publication date
ZA767689B (en) 1977-12-28
US4081528A (en) 1978-03-28
OA05524A (fr) 1981-04-30
JPS565368B2 (cs) 1981-02-04
PT66017A (en) 1977-01-01
DD129997A5 (de) 1978-03-01
SE7613959L (sv) 1977-07-03
CA1072012A (en) 1980-02-19
DE2659152A1 (de) 1977-07-14
HK30181A (en) 1981-07-10
SU1309901A3 (ru) 1987-05-07
EG12291A (en) 1978-09-30
AT345977B (de) 1978-10-10
ATA971776A (de) 1978-02-15
GR65305B (en) 1980-08-01
BG36493A3 (en) 1984-11-15
IN145845B (cs) 1979-01-06
LU76493A1 (cs) 1977-07-05
NL7614470A (nl) 1977-07-05
US4018889A (en) 1977-04-19
NL166620B (nl) 1981-04-15
AR209242A1 (es) 1977-03-31
CH616080A5 (cs) 1980-03-14
FR2336937B1 (cs) 1980-06-27
DK145753B (da) 1983-02-21
PT66017B (en) 1978-06-19
GB1520197A (en) 1978-08-02
US4086332A (en) 1978-04-25
DK584676A (da) 1977-07-03
IE44767B1 (en) 1982-03-24
KE3166A (en) 1981-11-06
FI56116C (fi) 1979-12-10
FI763716A7 (cs) 1977-07-03
JPS5290616A (en) 1977-07-30
BE849885A (fr) 1977-06-28
FI56116B (fi) 1979-08-31
DK145753C (da) 1983-08-08
CS205030B2 (en) 1981-04-30
IE44767L (en) 1977-07-02
NL166620C (nl) 1981-09-15
CA1075603A (en) 1980-04-15
DE2659152C2 (de) 1984-04-05
FR2336937A1 (fr) 1977-07-29
KR810000900B1 (ko) 1981-08-19
AU2057176A (en) 1978-09-28

Similar Documents

Publication Publication Date Title
SE435997B (sv) Forfarande for framstellning av en stabil losning av ett tetracyklinantibiotikum
DK531777A (da) Oploesning indeholdende stabil percarboxylsyre
FI782561A7 (fi) Aotergivningssystem foer underlaettande av uppstaellningen i ett avstaemningssystem
FI65861B (fi) Anordning foer genomfoering av ett radioimmunologiskt foerfarande
FI792757A7 (fi) Foerfarande foer framstaellning av ett intravenoest administrerbart motkroppar innehaollande immunoglobulinpreparat och enligt foerfarandet framstaellda produkter
SE441360B (sv) Forfarande for framstellning av fosfonsyraderivat
SE425131B (sv) Forfarande for framstellning av en depolaristorblandning av stabil silver (ii)oxid
FI780008A7 (fi) Anordning foer inspaenning av ett kassettfilter i ett filterhus
NO792237L (no) Fremgangsmaate for fremstilling av en 7-(substituert)amino-3-substituert tiometyl-delta3-cefem-4-karboksylsyre
SE426780B (sv) Forfarande for framstellning av ett cefalexinpreparat
NO801086L (no) Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et oksytetracyklin-chelat
FI783734A7 (fi) Undertryckande av stoerningar i krominanssignalen foerorsakade av luminanssignalen i ett behandlingssystem foer videosignaler
SE423880B (sv) Forfarande vid framstellning av ett enhetligt skikt ur en losning
FI772337A7 (fi) Anordning foer infaestning av ett kompaktfilter i en kassettram
SE432250B (sv) Forfarande for framstellning av ett kinazolinderivat
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE426069B (sv) Forfarande for framstellning av ett kristallint cefalosporinderivat
SE7707621L (sv) Forfarande for framstellning av xyloslosning
SE418312B (sv) Forfarande for framstellning av ett dubbelgolv
SE7701453L (sv) Forfarande for framstellning av ett grundemnesrikt mineralpreparat
FI783733A7 (fi) Undertryckande av stoerningar i krominanssignalen foerorsakade av luminanssignalen i ett behandlingssystem foer videosignaler
NO821484L (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
NO150965C (no) Fremgangsmaate for fremstilling av en xantanopploesning
SE434157B (sv) Forfarande for framstellning av 6-aminopenicillansyra
FI772338A7 (fi) Anordning foer infaestning av ett kompaktfilter i en kassettram

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7613959-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7613959-1

Format of ref document f/p: F